Sat.Mar 23, 2024

article thumbnail

High Frequency of OTC Product Misuse in Older Adults Highlights Areas for Pharmacists to Address

Drug Topics

Adults aged 65 years and older are the largest group of consumers of OTC medications.

212
212
article thumbnail

Pharmacist's Vital Role in RSV Vaccination: Shared Clinical Decision Making and Education

Pharmacy Times

Shared decision making with patients is a key component of RSV vaccination, which can bring challenges and opportunities.

Vaccines 153
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How Emotional Intelligence Helps Pharmacists Handle Controlled Substances Concerns

Drug Topics

Pharmacists must uphold their “corresponding responsibility” to address controlled substance concerns among patients while balancing safety and respect, said Mark Garofoli at this year’s American Pharmacists Association Annual Meeting & Exposition.

article thumbnail

Changing Mindset Is Crucial for Clinicians to Effectively Implement New Weight Management Medications

Pharmacy Times

In addition to improved efficacy, newer generations of anti-obesity medications have significantly improved safety concerns.

149
149
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Slideshow: Examining Preferences and Attitudes Around OTC Naloxone

Drug Topics

The first nonprescription, OTC naloxone nasal spray (Narcan) was approved by the FDA in March 2023.

FDA 123
article thumbnail

Expert: Pharmacogenomics Could Be Particularly Beneficial in the Psychiatric Setting

Pharmacy Times

Pharmacogenomics could help streamline prescribing and dosing for psychiatric medications, avoiding the trial-and-error process common with these medications.

123
123
article thumbnail

Expert Reviews New Data, Updates in Psychedelic Medicines

Pharmacy Times

Sa'ed Al-Olimat, PharmD, also discussed the potentially groundbreaking shift for MDMA expected later in 2024.

156
156